317-70-4

Basic information

• Product Name: 2-methoxy-1,3-dinitro-5-(trifluoromethyl)benzene
• Synonyms: 2-methoxy-1,3-dinitro-5-(trifluoromethyl)benzene
• CAS NO: 317-70-4
• Molecular Formula: C₈H₅F₃N₂O₅
• Molecular Weight: 266.1309096
• Mol File: 317-70-4.mol
• Article Data: 8

Chemical Properties

• Melting Point: 56-57 °C
• Boiling Point: 312.7±42.0 °C(Predicted)
• Appearance: /
• Density: 1.559±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 2-methoxy-1,3-dinitro-5-(trifluoromethyl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 2-methoxy-1,3-dinitro-5-(trifluoromethyl)benzene(317-70-4)
• EPA Substance Registry System: 2-methoxy-1,3-dinitro-5-(trifluoromethyl)benzene(317-70-4)

Safety Data

• Hazardous Substances Data: 317-70-4(Hazardous Substances Data)

Upstream product

• 393-75-9 4-chloro-3,5-dinitrobenzotrifluoride 
• 124-41-4 sodium methylate 
• 3315-60-4 methanolate 
• 28933-97-3 2,6-Dinitro-1,1-dimethoxy-4-trifluormethyl-cyclohexadienid 
• 67-56-1 methanol 

Downstream Products

• 28933-97-3 2,6-Dinitro-1,1-dimethoxy-4-trifluormethyl-cyclohexadienid 
• 2002-68-8 2,6-dinitro-4-(trifluoromethyl)phenylhydrazine 
• 71352-64-2 4-methoxy-3,5-diamino-α,α,α-trifluoromethylbenzene 

Relevant articles and documents

SOLID PHASE SUPPORT FOR NUCLEIC ACID SYNTHESIS AND METHOD FOR PRODUCING NUCLEIC ACID USING THE SAME

PROBLEM TO BE SOLVED: To provide a solid phase support that can be used in nucleic acid synthesis with high yield, high efficiency and high selectivity, and a method for producing a nucleic acid using the same. SOLUTION: A solid phase support for nucleic

Compound comprising urea and thiourea structures and synthesis method and application of compound

The invention relates to an organic small molecular compound comprising urea and thiourea structures in a formula I and a synthesis method and application of the compound. According to in-vitro antitumor activity tests, the compound has high antitumor act

FLUORINATED PHENYL-NAPHTHALENYL-UREA COMPOUNDS AS INHIBITORS OF CYTOKINES INVOLVED IN INFLAMMATORY PROCESSES

Disclosed are compounds of formula (I) wherein R1, R2, W and X of formula (I) are defined herein. The compounds inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.